Skip to main content

3 attractive markets for pharma expansion into Japan

Written on .

Expanding into Asia is a logical step for pharmaceutical companies looking to grow beyond Europe and North America. Japan’s current healthcare landscape makes it a strategic destination for international companies seeking expansion.

Here are 3 attractive markets for expansion that are gaining international attention:


Japan’s pharmaceutical market is gradually opening up to generic drugs, presenting a lucrative opportunity for international pharma companies. Traditionally, Japan has had a strong reliance on branded medications. However, the Japanese government is now actively promoting the use of generic drugs to reduce healthcare costs. As a result, the generic drug market in Japan is growing steadily. International pharmaceutical companies entering this market can benefit from the growing demand for high-quality, cost-effective generic medications.

Medical Equipment

Japan’s aging population and advanced healthcare infrastructure create a significant demand for cutting-edge medical equipment and devices. From diagnostic tools to surgical instruments and high-tech medical imaging devices, there is a substantial market for international companies specializing in medical equipment. Japan’s commitment to innovation and technology adoption means that there is a constant need for the latest advancements in healthcare technology.

Regenerative Medicine

The practical application of regenerative medicine in Japan has traditionally been less than in Western countries. Japan attempted to address this in 2014, with legislation to create a supportive regulatory environment for regenerative medicine and cell therapy, including expediting approvals for regenerative medicine products. This has led to advancements in the field, making Japan an attractive market for international pharmaceutical companies specializing in regenerative medicine. With a growing aging population and a rising need for innovative treatments, regenerative medicine has the potential to revolutionize healthcare in Japan. International companies with expertise in stem cell research, tissue engineering, and regenerative therapies can explore partnerships and investments in this rapidly evolving market.

While these markets present exciting opportunities, expanding into Japan’s pharmaceutical landscape also comes with its challenges. It’s essential for international pharmaceutical companies to conduct thorough market research, establish strong local partnerships, and navigate Japan’s regulatory framework.

At Morunda, we have cracked the code for hiring in Japan and Asia and specialize in market entries. From clinical trial to launch we have the right candidates to ensure your success. Book a discovery session.

Share This Post